Table 2.

Patients with Nocardia kroppenstedtii infection in the literature.

Case No.	References	Sex/age	Underlying disease	Immunosuppressive treatment for underlying disease	Systemic involvement of N. kroppenstedtii infection	Specimen(s) from which N. kroppenstedtii was isolated	Identification method	Antimicrobial treatment	Patient outcome
1	Jones et al. (4)	Not mentioned	Lung transplant	Not mentioned	Not mentioned	BAL	16S rDNA gene sequencing	Not mentioned	Not mentioned
2	Kilianski et al. (8)	M/72	Mantle cell lymphoma	Bendamustine, rituximab, bortezomib, ibrutinib, methotrexate, and methylprednisolone	CNS, cardiovascular system	Blood	16S rDNA gene sequencing	Meropenem, cotrimoxazole, levofloxacin, linezolid, ceftriaxone, minocycline, and ciprofloxacin	Succumbed
3	Majeed et al. (9)	F/59	Lung carcinoma	Radiotherapy, carboplatin, and etoposide	Eye, brain	Blood	Gene sequencing	Vancomycin, piperacillin-tazobactam, meropenem, and intravitreal injection of amikacin	Succumbed
4	Venkat et al. (10)	F/78	Autoimmune hemolytic anemia	Corticosteroid	Spine and spinal cord	Pus	16S rDNA gene sequencing	Cloxacillin, cotrimoxazole, and carbapenem	Improved
5	Present case	F/71	Adult Still's disease	Dexamethasone, methylprednisolone, cyclosporin A, and tocilizumab	Lung	Blood, BAL, and pleural effusion	16S rDNA target NGS	Meropenem, vancomycin, micafungin, imipenem-cilastatin, amikacin, cotrimoxazole, ceftriaxone, and tigecycline	Succumbed

BAL, bronchoalveolar lavage; CNS, central nervous system; NGS, next-generation sequencing.